Mesothelioma Clinical Trials Search Tool
Find and explore mesothelioma clinical trials with our easy-to-use search tool and get connected with doctors conducting them. Search by location, trial phase, and specific disease presentation to discover cutting-edge treatment opportunities that may fit your diagnosis.
FILTER BY:
Details
Olaparib in Patients With HRD Malignant Mesothelioma
Address: 5700 S Maryland Ave, Chicago, IL 60637, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: Yes
- Peritoneal: Yes
- Pericardial: Yes
- Tunica Vaginalis: Yes
- Therapy Targeted: No
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Mesothelioma, Homologous Recombination Deficiency
Description: In this study, researchers will give olaparib (a drug) to mesothelioma patients who have specific changes in their DNA (known as gene mutations). Researchers will give this drug to each patient on the study to find out if it will help the patient's tumor shrink or stop growing.
Research Center: University of Chicago Medicine
Treatment Interventions: DRUG: Olaparib
Clinical Trial Number: NCT04515836
Phase: Phase 2
Status:
